In vitro susceptibility and cellular uptake for a new class of antimicrobial agents: Dinuclear ruthenium(II) complexes

Journal of Antimicrobial Chemotherapy

Volumn 67, Issue 11, 2012, Pages 2686-2695

  Li, Fangfei ^a   Feterl, Marshall ^b   Mulyana, Yanyan ^b   Warner, Jeffrey M ^b   Collins, J Grant ^a   Keene, F Richard ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b JAMES COOK UNIVERSITY   (Australia)

Author keywords

Bactericidal metal complexes; Cellular accumulation; MBCs; MICs; Time kill curves

Indexed keywords

AMPICILLIN; GENTAMICIN; RUTHENIUM COMPLEX;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERICIDAL ACTIVITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG DETERMINATION; DRUG SYNTHESIS; DRUG UPTAKE; ESCHERICHIA COLI; IN VITRO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

ANTI-INFECTIVE AGENTS; ESCHERICHIA COLI; FLOW CYTOMETRY; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; MICROSCOPY, CONFOCAL; PSEUDOMONAS AERUGINOSA; RUTHENIUM; STAPHYLOCOCCUS AUREUS;

EID: 84867597984     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dks291     Document Type: Article

References (28)

1. Boucher HW, Talbot GH, Bradley JS et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 2009; 48: 1-12.
2. Theuretzbacher U. Resistance drives antibacterial drug development. Curr Opin Pharmacol 2011; 11: 433-8.
3. Li F, Mulyana Y, Feterl M et al. The antimicrobial activity of inert oligonuclear polypyridylruthenium(II) complexes against pathogenic bacteria, including MRSA. Dalton Trans 2011; 40: 5032-8.
4. Dwyer FP, Gyarfas EC, Rogers WP et al. Biological activity of complex ions. Nature 1952; 170: 190-1.
5. Dwyer FP, Reid IK, Shulman A et al. The biological actions of 1,10-phenanthroline and 2,2'-bipyridine hydrochloride, quaternary salts, and metal chelates and related compounds. 1. Bacteriostatic action on selected gram-positive, gram-negative and acid-fast bacteria. Aust J Exp Biol Med Sci 1969; 47: 203-18.
6. Anthonysamy A, Balasubramanian S, Shanmugaiah V et al. Synthesis, characterization and electrochemistry of 4'-functionalized 2,2':6',2''-terpyridine ruthenium(II) complexes and their biological activity. Dalton Trans 2008; 2136-43.
7. 2+ complexes and their antimicrobial activity. Appl Organometal Chem 2009; 23: 409-20.
8. Offiong OE, Etok C, Martelli S. Synthesis and biological activity of platinum group metal complexes of o-vanillin thiosemicarbazones. Farmaco 1996; 51: 801-8.
9. Bolhuis A, Hand L, Marshall JE et al. Antimicrobial activity of ruthenium-based intercalators. Eur J Pharm Sci 2011; 42: 313-7.
10. Thangadurai TD, Natarajan K. Antibacterial activity of ruthenium(II) carbonyl complexes containing tetradentate Schiff bases. Trans Metal Chem 2002; 27: 485-9.
11. Mazumder UK, Gupta M, Bhattacharya S et al. Antineoplastic and antibacterial activity of some mononuclear Ru(II) complexes. J Enzyme Inhib Med Chem 2004; 19: 185-92.
12. Mulyana Y, Weber DK, Buck DP et al. Oligonuclear polypyridylruthenium(II) complexes incorporating flexible polar and non-polar bridges: synthesis, DNA binding and cytotoxicity. Dalton Trans 2011; 40: 1510-23.
13. 4+ [dppm is 4,6-bis(2-pyridyl)pyrimidine; phen is 1,10-phenanthroline]. J Biol Inorg Chem 2006; 11: 824-34.
14. Performance Standards for Antimicrobial Susceptibility Testing: Nineteenth Informational Supplement, M100-S19.
15. 13A
16. Halouska S, Fenton RJ, Barletta RG et al. Predicting the in vivo mechanism of action for drug leads using NMR metabolomics. ACS Chem Biol 2012; 7: 166-71.
17. Carcelli M, Mazza P, Pelizzi C et al. Antimicrobial and genotoxic activity of 2,6-diacetylpyridine bis(acylhydrazones) and their complexes with some first transition series metal ions. X-ray structure of a dinuclear copper(II) complex. J Inorg Biochem 1995; 57: 43-62.
18. Prabu R, Vijayaraj A, Suresh R et al. Electrochemical, catalytic and antimicrobial activity of N-functionalized tetraazamacrocyclic binuclear nickel(II) complexes. Spectrochim Acta A Mol Biomol Spectrosc 2011; 78: 601-6.
19. Richards AD, Rodger A, Hannon MJ et al. Antimicrobial activity of an iron triple helicate. Intl J Antimicrob Agents 2009; 33: 469-72.
20. Howson SE, Bolhuis A, Brabec V et al. Optically pure, water-stable, metallo-helical 'fexicate' assemblies with antibiotic activity. Nature Chem 2012; 4: 31-6.
21. Pisani MJ, Weber DK, Heimann K et al. Selective mitochondrial accumulation of cytotoxic dinuclear polypyridyl ruthenium(II) complexes. Metallomics 2010; 2: 393-6.
22. Gill MR, Garcia-Lara J, Foster SJ et al. A ruthenium(II) polypyridyl complex for direct imaging of DNA structure in living cells. Nature Chem 2009; 1: 662-7.
23. Ellison RT, Larforce FM, Giehl TJ et al. Lactoferrin and transferrin damage of the Gram-negative outer membrane is modulated by calcium and magnesium. J Gen Microbiol 1990; 136: 1437-46.
24. Chen CZ, Cooper SL. Interactions between dendrimer biocides and bacterial membranes. Biomaterials 2002; 23: 3359-68.
25. Pisani MJ, Fromm PD, Clarke R et al. Mechanism of cytotoxicity and cellular uptake of lipophilic inert dinuclear polypyridylruthenium(II) complexes. Chem Med Chem 2011; 6: 848-58.
26. Gilbert P, Moore LE. Cationic antiseptics: diversity of action under a common epithet. J Appl Microbiol 2005; 99: 703-15.
27. Mader JS, Hoskin DW. Cationic antimicrobial peptides as novel cytotoxic agents for cancer treatment. Expert Opin Investig Drugs 2006; 15: 933-46.